Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson&rsquo;s disease

Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson&rsquo;s disease

P Bossolasco1,*, L Cova2,*, G Levandis3, V Diana2, S Cerri3, G Lambertenghi Deliliers1, E Polli1, V Silani2,4, F Blandini3, MT Armentero31Fondazione Matarelli, Dipartimento di Farmacologia, Chemioterapia e Tossicologia Medica, Universit&agrave; degli Studi di Milano, Milan, 2Department of Ne...

Full description

Bibliographic Details
Main Authors:	Bossolasco P, Cova L, Levandis G, Diana V, Cerri S, Lambertenghi Deliliers G, Polli E, Silani V, Blandini F, Armentero MT
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-01-01
Series:	International Journal of Nanomedicine
Online Access:	http://www.dovepress.com/noninvasive-near-infrared-live-imaging-of-human-adult-mesenchymal-stem-a9163

Similar Items

Transplantation of Undifferentiated Human Mesenchymal Stem Cells Protects against 6-Hydroxydopamine Neurotoxicity in the Rat
by: Fabio Blandini M.D., et al.
Published: (2010-02-01)

Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease
by: Marie-Therese Armentero, et al.
Published: (2011-09-01)

Peripheral inflammation and neuroprotection: Systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease
by: Marie-Thérèse Armentero, et al.
Published: (2006-12-01)

Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease
by: Giovanna Levandis, et al.
Published: (2008-01-01)

Induction of Neurotrophin Expression via Human Adult Mesenchymal Stem Cells: Implication for Cell Therapy in Neurodegenerative Diseases
by: Federica Pisati, et al.
Published: (2007-01-01)

Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?
by: Marie Therese Fuzzati-Armentero, et al.
Published: (2019-03-01)

Neuroprotective compounds and innovative therapeutic strategies for Parkinson&rsquo;s disease: experimental and clinical studies
by: Fabio Blandini
Published: (2009-09-01)

Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease
by: Marie-Thérèse Armentero, et al.
Published: (2006-04-01)

Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
by: Francesca Siani, et al.
Published: (2017-05-01)

Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease
by: Micol Avenali, et al.
Published: (2020-04-01)

Validation study of the Parkinson’s Fatigue Scale in advanced Parkinson’s disease
by: Martinez-Martin P, et al.
Published: (2019-04-01)

In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease
by: Nicoletta Rizzi, et al.
Published: (2018-06-01)

Predictors of caregivers’ burden of Parkinson’s disease in India: experience of a tertiary care center in India
by: Agrawal V, et al.
Published: (2012-11-01)

Dose dependent side effect of superparamagnetic iron oxide nanoparticle labeling on cell motility in two fetal stem cell populations.
by: Valentina Diana, et al.
Published: (2013-01-01)

Parkinson’s disease psychosis
by: Jakel RJ, et al.
Published: (2014-03-01)

Potential therapeutic effects of polyphenols in Parkinson's disease: in vivo and in vitro pre-clinical studies
by: Claudio Giuliano, et al.
Published: (2021-01-01)

Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells
by: Giulia Ambrosi, et al.
Published: (2015-10-01)

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
by: Kose Ozlece H, et al.
Published: (2018-07-01)

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden
by: Modugno N, et al.
Published: (2020-12-01)

Noninvasive ventilation: has Pandora&rsquo;s box been opened?
by: Ari Manuel, et al.
Published: (2010-02-01)

Therapeutic deep brain stimulation worsening dysprosody in Parkinson’s disease – an unexplored entity
by: Shoaib M, et al.
Published: (2018-03-01)

Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents
by: Salemi Vera, et al.
Published: (2007-04-01)

Patients&rsquo; and caregivers&rsquo; experiences of the impact of Parkinson&rsquo;s disease on health status
by: Horacio Chiong-Rivero, et al.
Published: (2011-03-01)

Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
by: Patrizia Bossolasco, et al.
Published: (2017-04-01)

Exosome microRNAs in Amyotrophic Lateral Sclerosis: A Pilot Study
by: Francesca Pregnolato, et al.
Published: (2021-08-01)

The Current Evidence for the Use of Safinamide for the Treatment of Parkinson’s Disease
by: Abbruzzese G, et al.
Published: (2021-06-01)

Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China
by: Zou YM, et al.
Published: (2015-06-01)

Parkinson’s disease-associated melanin steal
by: Hinz M, et al.
Published: (2014-12-01)

Rasagiline in treatment of Parkinson&rsquo;s disease
by: Lakshmi Nayak, et al.
Published: (2008-03-01)

Neuropsychiatric symptoms in untreated Parkinson’s disease
by: Szatmari S, et al.
Published: (2017-03-01)

The role of rasagiline in the treatment of Parkinson’s disease
by: Julie Leegwater-Kim, et al.
Published: (2010-05-01)

Parkinson’s disease managing reversible neurodegeneration
by: Hinz M, et al.
Published: (2016-04-01)

Sleep disorders in Parkinson&rsquo;s disease
by: Israt Jahan, et al.
Published: (2009-10-01)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
by: Kristinsson J, et al.
Published: (2012-11-01)

Parkinson’s disease-associated dysarthria: prevalence, impact and management strategies
by: Moya-Galé G, et al.
Published: (2019-05-01)

Depression and Related Factors in Patients with Parkinson’s Disease at High Altitude
by: Cao Y, et al.
Published: (2021-05-01)

Descriptive symptom terminology used by Parkinson’s patients and caregivers
by: Mursaleen LR, et al.
Published: (2017-11-01)

Effects of carbonated liquid on swallowing dysfunction in dementia with Lewy bodies and Parkinson’s disease dementia
by: Larsson V, et al.
Published: (2017-08-01)

Distribution of non-motor symptoms in idiopathic Parkinson’s disease and secondary Parkinsonism
by: Skogar O, et al.
Published: (2018-10-01)

Modeling Parkinson’s Disease: Not Only Rodents?
by: Maria Shadrina, et al.
Published: (2021-08-01)